Serina Therapeutics annual gross profit
2017
2018
2019
2020
2021
2022
2023
Serina Therapeutics Gross Profit Growth & History (SER)
Serina Therapeutics's gross profit was $102,000 for fiscal 2023.
View full Serina Therapeutics company overviewSerina Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $102,000 | $81,000 | +385.71% |
| 2022 | 2022-12-31 | $21,000 | −$104,000 | −83.20% |
| 2021 | 2021-12-31 | $125,000 | −$210,000 | −62.69% |
| 2020 | 2020-12-31 | $335,000 | −$1.1M | −77.43% |
| 2019 | 2019-12-31 | $1.5M | $452,000 | +43.80% |
| 2018 | 2018-12-31 | $1.0M | −$204,000 | −16.50% |
| 2017 | 2017-12-31 | $1.2M | — | — |
Serina Therapeutics quarterly gross profit
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $55,000 | $48,000 | +685.71% |
| Q3 2023 | 2023-09-30 | $34,000 | $30,000 | +750.00% |
| Q2 2023 | 2023-06-30 | $4,000 | −$2,000 | −33.33% |
| Q1 2023 | 2023-03-31 | $9,000 | $5,000 | +125.00% |
| Q4 2022 | 2022-12-31 | $7,000 | −$19,000 | −73.08% |
| Q3 2022 | 2022-09-30 | $4,000 | −$18,000 | −81.82% |
| Q2 2022 | 2022-06-30 | $6,000 | −$18,000 | −75.00% |
| Q1 2022 | 2022-03-31 | $4,000 | −$49,000 | −92.45% |
| Q4 2021 | 2021-12-31 | $26,000 | −$127,000 | −83.01% |
| Q3 2021 | 2021-09-30 | $22,000 | −$30,000 | −57.69% |
| Q2 2021 | 2021-06-30 | $24,000 | −$18,000 | −42.86% |
| Q1 2021 | 2021-03-31 | $53,000 | −$35,000 | −39.77% |
| Q4 2020 | 2020-12-31 | $153,000 | −$317,000 | −67.45% |
| Q3 2020 | 2020-09-30 | $52,000 | −$310,000 | −85.64% |
| Q2 2020 | 2020-06-30 | $42,000 | −$285,000 | −87.16% |
| Q1 2020 | 2020-03-31 | $88,000 | −$237,000 | −72.92% |
| Q4 2019 | 2019-12-31 | $470,000 | $337,000 | +253.38% |
| Q3 2019 | 2019-09-30 | $362,000 | −$22,000 | −5.73% |
| Q2 2019 | 2019-06-30 | $327,000 | −$58,000 | −15.06% |
| Q1 2019 | 2019-03-31 | $325,000 | $195,000 | +150.00% |
| Q4 2018 | 2018-12-31 | $133,000 | — | — |
| Q3 2018 | 2018-09-30 | $384,000 | — | — |
| Q2 2018 | 2018-06-30 | $385,000 | — | — |
| Q1 2018 | 2018-03-31 | $130,000 | — | — |
Serina Therapeutics gross profit trends
Over the last five fiscal years, Serina Therapeutics's gross profit decreased from $1.0M to $102,000, a change of −$930,000. The latest reported quarter, Q4 2023, shows $55,000.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Serina Therapeutics source filings ↗